BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 10469123)

  • 1. PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis.
    Besson A; Robbins SM; Yong VW
    Eur J Biochem; 1999 Aug; 263(3):605-11. PubMed ID: 10469123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The complexity of PTEN: mutation, marker and potential target for therapeutic intervention.
    Steelman LS; Bertrand FE; McCubrey JA
    Expert Opin Ther Targets; 2004 Dec; 8(6):537-50. PubMed ID: 15584861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta.
    Li DM; Sun H
    Cancer Res; 1997 Jun; 57(11):2124-9. PubMed ID: 9187108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The INPP4B paradox: Like PTEN, but different.
    Hamila SA; Ooms LM; Rodgers SJ; Mitchell CA
    Adv Biol Regul; 2021 Dec; 82():100817. PubMed ID: 34216856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN: life as a tumor suppressor.
    Simpson L; Parsons R
    Exp Cell Res; 2001 Mar; 264(1):29-41. PubMed ID: 11237521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TEP1, the yeast homolog of the human tumor suppressor gene PTEN/MMAC1/TEP1, is linked to the phosphatidylinositol pathway and plays a role in the developmental process of sporulation.
    Heymont J; Berenfeld L; Collins J; Kaganovich A; Maynes B; Moulin A; Ratskovskaya I; Poon PP; Johnston GC; Kamenetsky M; DeSilva J; Sun H; Petsko GA; Engebrecht J
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12672-7. PubMed ID: 11070083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTEN and myotubularin: novel phosphoinositide phosphatases.
    Maehama T; Taylor GS; Dixon JE
    Annu Rev Biochem; 2001; 70():247-79. PubMed ID: 11395408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: differential involvement of focal adhesion kinase and p130Cas.
    Tamura M; Gu J; Takino T; Yamada KM
    Cancer Res; 1999 Jan; 59(2):442-9. PubMed ID: 9927060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pten signaling in gliomas.
    Knobbe CB; Merlo A; Reifenberger G
    Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of action of the tumour suppressor gene PTEN.
    Hlobilková A; Knillová J; Bártek J; Lukás J; Kolár Z
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2003 Nov; 147(1):19-25. PubMed ID: 15034601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway.
    Wu X; Senechal K; Neshat MS; Whang YE; Sawyers CL
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15587-91. PubMed ID: 9861013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells.
    Li DM; Sun H
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15406-11. PubMed ID: 9860981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways.
    Gu J; Tamura M; Yamada KM
    J Cell Biol; 1998 Nov; 143(5):1375-83. PubMed ID: 9832564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cowden disease].
    Sawada T; Hamano N; Suzuki A; Okada T; Mabuchi H
    Nihon Rinsho; 2000 Jul; 58(7):1479-83. PubMed ID: 10921327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting mutants of PTEN reveal distinct subsets of tumour suppressor functions.
    Leslie NR; Bennett D; Gray A; Pass I; Hoang-Xuan K; Downes CP
    Biochem J; 2001 Jul; 357(Pt 2):427-35. PubMed ID: 11439092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.
    Maehama T; Dixon JE
    J Biol Chem; 1998 May; 273(22):13375-8. PubMed ID: 9593664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis.
    Davies MA; Lu Y; Sano T; Fang X; Tang P; LaPushin R; Koul D; Bookstein R; Stokoe D; Yung WK; Mills GB; Steck PA
    Cancer Res; 1998 Dec; 58(23):5285-90. PubMed ID: 9850049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway.
    Ramaswamy S; Nakamura N; Vazquez F; Batt DB; Perera S; Roberts TM; Sellers WR
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2110-5. PubMed ID: 10051603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene.
    Li J; Simpson L; Takahashi M; Miliaresis C; Myers MP; Tonks N; Parsons R
    Cancer Res; 1998 Dec; 58(24):5667-72. PubMed ID: 9865719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTEN gene and integrin signaling in cancer.
    Tamura M; Gu J; Tran H; Yamada KM
    J Natl Cancer Inst; 1999 Nov; 91(21):1820-8. PubMed ID: 10547389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.